Partnership for Prevention President/CEO Robert J. Gould Ph.D. applauded the support for disease prevention and health promotion that is provided in the health reform bill to be voted on the by the House of Representatives over the weekend.
"I wanted you to know that Partnership for Prevention strongly supports the prevention provisions of HR 3962, the 'Affordable Health Care for America Act.' Gould said in a letter to House Majority Whip Steny L. Hoyer, D-Md.
"We believe the provisions of HR 3962 establishing a dedicated national trust fund for prevention, wellness and public health will enable thousands of U.S. communities to help citizens quit tobacco, become more physically active, and reduce their risk of life-threatening diseases," Gould added. "Only by addressing these primary drivers of poor health and high health care costs can we foster community environments that will enable American families to support healthy behaviors and healthy choices."
Friday, 6 November 2009
New Medicaid Study Highlights Tobacco Cessation Coverage
Forty-three states now cover some form of cessation treatment for Medicaid beneficiaries, up from 23 states in 1998, according to the Nov. 6 issue of Morbidity and Mortality Weekly Report (MMWR), which summarizes coverage of tobacco dependence treatment under the Medicaid program, reported that. However, only six states cover all of the effective pharmacotherapies and individual and group counseling.
Smoking rates among Medicaid enrollees are much higher than among the general population – 4.7 million smokers. This represents 33% of the total Medicaid population and adds to nearly $22 billion in annual Medicaid expenditures related to smoking. Numerous studies have found that tobacco cessation treatments are highly cost effective. Yet many barriers exist, preventing greater access to those who need and want help to quit tobacco use.
Partnership for Prevention and the Call for ACTTION initiative encourage the federal government and states to implement the updated 2008 Public Health Service Clinical Practice Guidelines which call for access to comprehensive coverage of all effective treatments – counseling and medication without barriers and limitations.
Diane M. Canova
Managing Senior Fellow
& Senior Program Officer
Partnership for Prevention
Smoking rates among Medicaid enrollees are much higher than among the general population – 4.7 million smokers. This represents 33% of the total Medicaid population and adds to nearly $22 billion in annual Medicaid expenditures related to smoking. Numerous studies have found that tobacco cessation treatments are highly cost effective. Yet many barriers exist, preventing greater access to those who need and want help to quit tobacco use.
Partnership for Prevention and the Call for ACTTION initiative encourage the federal government and states to implement the updated 2008 Public Health Service Clinical Practice Guidelines which call for access to comprehensive coverage of all effective treatments – counseling and medication without barriers and limitations.
Diane M. Canova
Managing Senior Fellow
& Senior Program Officer
Partnership for Prevention
Partnership Board Member Will Serve as APHA President
Dr. Carmen Nevarez , vice president of the Public Health Institute and a member of Partnership for Prevention's Board of Directors, will become the 138th president of the American Public Health Association (APHA) at the organization's annual meeting in Philadelphia.
During her one-year term as president, Nevarez will serve as an "ambassador" for APHA, speaking at meetings and conferences around the country, and as a representative on various boards, committees or other initiatives outside of APHA. Founded in 1872, the 30,000-member APHA is the oldest, largest and most diverse organization of public health professionals in the world.
During her one-year term as president, Nevarez will serve as an "ambassador" for APHA, speaking at meetings and conferences around the country, and as a representative on various boards, committees or other initiatives outside of APHA. Founded in 1872, the 30,000-member APHA is the oldest, largest and most diverse organization of public health professionals in the world.
Wednesday, 4 November 2009
Prevention Shouldn't Apologize for Helping People Live Longer, Gould Tells Nation's Health
From the November issue of The Nation's Health:
Prevention, a touchstone of public health, has landed in the crosshairs of the national health reform debate, with cost-effectiveness pitted against the sometimes incalculable value of a healthy life....
...With such questions coming to the forefront, the task ahead is to reframe the prevention debate, said Rob Gould, PhD, president of the Partnership for Prevention. Focusing on how much money prevention costs or saves the federal budget is the wrong question, Gould told The Nation’s Health. Instead, the discussion should focus on questions of value, he said, whether the money being spent is a good investment.
"We should not be apologizing for helping people live longer and healthier lives, especially when we can deliver that life at the right cost," said Gould, an APHA member. "The good news is that the public wants prevention in health care, even if it costs more, so we’re starting from a good place in terms of public support. But we have to answer the economic questions, and we need to talk about cost in terms of value."
In September, the Partnership for Prevention released and sent to policy-makers a report on the "Economic Argument for Disease Prevention: Distinguishing Between Value and Savings," which stated that "health is a good, and goods — whether they are national security, clean water or a new car — are not purchased to save money. They are purchased for the nonmonetary benefits they provide. Shoppers do not buy groceries to save money, but they do ‘save money’ by shopping wisely."
The report noted that prevention can result in other benefits that usually go unmeasured in studies on cost-effectiveness, such as improving "work force productivity and corporate competitiveness," as well as the ripple effects good health can bring to households and children, educational attainment and crime rates. A similar report released in August by the Robert Wood Johnson Foundation, "Cost-Savings and Cost-Effectiveness of Clinical Preventive Care," found that even while clinic-based preventive care, such as cancer screenings, do not usually result in cost savings, such services "offer good value for increasingly scarce health care dollars."
Prevention, a touchstone of public health, has landed in the crosshairs of the national health reform debate, with cost-effectiveness pitted against the sometimes incalculable value of a healthy life....
...With such questions coming to the forefront, the task ahead is to reframe the prevention debate, said Rob Gould, PhD, president of the Partnership for Prevention. Focusing on how much money prevention costs or saves the federal budget is the wrong question, Gould told The Nation’s Health. Instead, the discussion should focus on questions of value, he said, whether the money being spent is a good investment.
"We should not be apologizing for helping people live longer and healthier lives, especially when we can deliver that life at the right cost," said Gould, an APHA member. "The good news is that the public wants prevention in health care, even if it costs more, so we’re starting from a good place in terms of public support. But we have to answer the economic questions, and we need to talk about cost in terms of value."
In September, the Partnership for Prevention released and sent to policy-makers a report on the "Economic Argument for Disease Prevention: Distinguishing Between Value and Savings," which stated that "health is a good, and goods — whether they are national security, clean water or a new car — are not purchased to save money. They are purchased for the nonmonetary benefits they provide. Shoppers do not buy groceries to save money, but they do ‘save money’ by shopping wisely."
The report noted that prevention can result in other benefits that usually go unmeasured in studies on cost-effectiveness, such as improving "work force productivity and corporate competitiveness," as well as the ripple effects good health can bring to households and children, educational attainment and crime rates. A similar report released in August by the Robert Wood Johnson Foundation, "Cost-Savings and Cost-Effectiveness of Clinical Preventive Care," found that even while clinic-based preventive care, such as cancer screenings, do not usually result in cost savings, such services "offer good value for increasingly scarce health care dollars."
Partnership President Calls for Creating a "Culture of Health"
In a recent Chicago Tribune interview, Partnership for Prevention President Robert J. Gould said making healthy choices easier will help create a "culture of health."
"If we lower the barriers to making healthier choices in the community, then we can create a culture of health in this country," Gould told Tribune reporter Julie Deardorff.
Deardorff's article undescored Gould's assertion by citing a recent report in the Archives of Internal Medicine. That study found that people who live in "healthy" neighborhoods -- areas with plentiful opportunities for physical activity and eating well -- had a 38 percent lower rate of Type 2 diabetes than those in "unhealthy" neighborhoods.
"If we lower the barriers to making healthier choices in the community, then we can create a culture of health in this country," Gould told Tribune reporter Julie Deardorff.
Deardorff's article undescored Gould's assertion by citing a recent report in the Archives of Internal Medicine. That study found that people who live in "healthy" neighborhoods -- areas with plentiful opportunities for physical activity and eating well -- had a 38 percent lower rate of Type 2 diabetes than those in "unhealthy" neighborhoods.
Tuesday, 3 November 2009
"Medical Home" Program, Toxic Halloween Face Paint Named "Best, Worst Prevention Ideas of the Week"
Medicare’s decision to help ramp up “medical home” demonstration programs was named Partnership for Prevention’s “Best Prevention Idea of the Week,” while reports of toxic Halloween face paint was named “Worst Prevention Idea of the Week.”
The Best/Worst Idea awards are a regular feature of Prevention Matters , the blog of Partnership for Prevention. Each week, Partnership for Prevention's staff will choose the designees based on nominations of items in the previous week's news submitted by members, staff and the public at large. To submit a nomination or for more information, contact Damon Thompson at dthompson@prevent.org.
BEST
Medicare backs state medical home projects
The U.S. Department of Health and Human Services will join state multi-payer patient-centered medical home demonstration programs next year as a contributing payer. The demonstrations will build on a model tested in Vermont for three years. Under the Vermont model, private insurers work with Medicaid to set uniform standards for medical homes, which emphasize prevention, health information technology, care coordination and shared decision making among patients and their providers.
WORST
Toxins Make Halloween Face Paints Scary
http://health.usnews.com/articles/health/healthday/2009/10/27/toxins-make-halloween-face-paints-scary.html
Halloween face paint could contain a nasty trick for children. A test of 10 face paint products widely available via the Internet or in craft or Halloween stores showed that all 10 face paint products tested contained lead, and six out of 10 had known skin allergens, including nickel, cobalt or chromium, at levels above recommendations of industry studies. The findings were outlined in a report issued by the Campaign for Safe Cosmetics entitled: Pretty Scary: Could Halloween Face Paint Cause Lifelong Health Problems? Earlier this year, a face paint from China was recalled by the U.S. Food and Drug Administration when some children had rashes and itching; the FDA later found microbial contamination in the product.Monday, 2 November 2009
Partnership Board Vice Chair Named Chair of ABA's Science & Tech Law Section
Christine M. Grant, Vice Chair of Partnership for Prevention's Board of Directors, is serving as chair of the American Bar Association Section of Science & Technology Law. Grant took office at the conclusion of the 2009 ABA Annual Meeting in Chicago.
The ABA Section of Science & Technology Law provides leadership on emerging issues at the intersection of law, science, and technology; to promote sound policy and public understanding on such issues; and to enhance the professional development of its members. The Section has over 13,000 members, with diverse backgrounds in areas such as e-commerce law, Internet law, computer law, communications law, and law relating to engineering, physics, biology, and medicine. It works through 26 substantive committees to explore topics such as e-commerce, information security, privacy, the Internet, digital evidence, animal law, rights and responsibilities of scientists, nanotechnology, homeland security and bio-technology and the law.
Grant is CEO of InfecDetect LLC in Princeton, N.J., a company focused on preventing infectious disease through rapid diagnostic tests, protective gear and food safety products. She is a former commissioner of New Jersey health and senior services, and has served five New Jersey governors. She is also a former senior executive at two global pharmaceutical companies, Merck & Co. and what was formerly Aventis Pasteur, now known as Sanofi Pasteur.
The ABA Section of Science & Technology Law provides leadership on emerging issues at the intersection of law, science, and technology; to promote sound policy and public understanding on such issues; and to enhance the professional development of its members. The Section has over 13,000 members, with diverse backgrounds in areas such as e-commerce law, Internet law, computer law, communications law, and law relating to engineering, physics, biology, and medicine. It works through 26 substantive committees to explore topics such as e-commerce, information security, privacy, the Internet, digital evidence, animal law, rights and responsibilities of scientists, nanotechnology, homeland security and bio-technology and the law.
Grant is CEO of InfecDetect LLC in Princeton, N.J., a company focused on preventing infectious disease through rapid diagnostic tests, protective gear and food safety products. She is a former commissioner of New Jersey health and senior services, and has served five New Jersey governors. She is also a former senior executive at two global pharmaceutical companies, Merck & Co. and what was formerly Aventis Pasteur, now known as Sanofi Pasteur.
Subscribe to:
Posts (Atom)
